Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara
In this episode Matt will be joined by Chris Behrenbruch from Telix Pharmaceuticals and David Blake.
In this episode Matt will be joined by Chris Behrenbruch from Telix Pharmaceuticals and David Blake.